Histogen Inc.
HSTODelisted Oct 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001383701
Histogen Inc. was delisted on Oct 12, 2023; its insiders filed their last Form 4 on Jun 21, 2023; 9 institutions reported holding it in 13F filings for Q3 2023, worth $9.53K in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Histogen Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 13 | 13 | 0 |
| Shares | 129.1K | 108.5K | −20.5K (−15.9%) |
| Value | $174.0K | $90.4K | −$83.6K (−48.0%) |
New holders (3)
Institutions that held Histogen Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 13,182 | $10.9K | 0.00% |
| Renaissance Technologies LLC | 10,600 | $9.00K | 0.00% |
| Benjamin F. Edwards & Company, Inc. | 5 | $0 | 0.00% |
Sold out (3)
Institutions that held Histogen Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Virtu Financial LLC | 27,227 | $37.0K |
| Prudential Financial Inc | 19,400 | $26.0K |
| Morgan Stanley | 2,575 | $3.00K |